Chlamydia screening in community pharmacies: a systematic literature review of the characteristics of service users and a meta-analysis of chlamydia prevalence

Sexual Health ◽  
2013 ◽  
Vol 10 (1) ◽  
pp. 1 ◽  
Author(s):  
Mufiza Zia Kapadia

A systematic review was undertaken to estimate the prevalence of chlamydia (Chlamydia trachomatis) infection among those screened in community pharmacies. The uptake of screening and clients’ sociodemographic and behavioural characteristics were also reviewed. Eleven papers contributed to the final review. The proportional meta-analysis showed a chlamydia positivity of 8.1% (95% confidence interval: 7.3%–8.9%). Chlamydia screening programs in community pharmacies tended to be targeted at certain client groups such as those seeking emergency contraception in pharmacies. The pharmacists were reluctant to offer chlamydia screening to potential clients. The uptake of the service was much lower, and tended not to include men and ethnic minorities.

2012 ◽  
Vol 12 (1) ◽  
Author(s):  
Dyani Lewis ◽  
Danielle C Newton ◽  
Rebecca J Guy ◽  
Hammad Ali ◽  
Marcus Y Chen ◽  
...  

2011 ◽  
Vol 9 (3) ◽  
pp. 332-336
Author(s):  
João Bosco Ramos Borges ◽  
Ana Carolina Marchesini ◽  
Luciana Francine Bocchi De Stefani ◽  
Marcus Vinícius Gonçalves Belintani ◽  
Thaís Andrea dos Santos

ABSTRACT Objective: To estimate the prevalence of Chlamydia trachomatis in a population with a high risk of sexually transmitted diseases and to compare data of the literature and the relationship of infection with the presence of human papilloma virus induced lesions. Methods: A total of 28 hybrid capture tests for C. trachomatis were collected from patients referred to the Municipal Health Division of the city of Jundiaí (SP) for the lower genital tract pathology. The results were compared with findings in the literature, and with the test results from a general population of the city of Jundiaí. Results: Of the 28 tests, 3 (10.7%) were positive. We did not find a positive association between C. trachomatis infection and the presence or aggravation of intraepithelial cervical cancer. Conclusion: Our findings showed a high prevalence of C. trachomatis infection in the population studied, but no association with human papilloma virus infection. Because the number of patients assessed was small, it is difficult to generalize from our findings. We suggest there is a need to expand screening programs for C. trachomatis, mainly in symptomatic patients and in those patients with cervical changes.


Lung Cancer ◽  
2020 ◽  
Vol 146 ◽  
pp. 134-144
Author(s):  
Andrew C.L. Lam ◽  
Reenika Aggarwal ◽  
Serina Cheung ◽  
Erin L. Stewart ◽  
Gail Darling ◽  
...  

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Pengcheng Huai ◽  
Furong Li ◽  
Tongsheng Chu ◽  
Dianchang Liu ◽  
Jian Liu ◽  
...  

2016 ◽  
Vol 29 (10) ◽  
pp. 583
Author(s):  
Diogo Libânio ◽  
Luís Filipe Azevedo

Although colonoscopy is considered the most accurate test for the investigation of colorectal polyps, lesions ≤ 10 mm may be missed in approximately 10%. Chromoscopy may increase the detection of colorectal polyps. A systematic review and meta-analysis was performed to investigate the benefit of cromoscopy in colorectal polyps detection. Seven randomized controlled trials were included (incuding 2,727 participants) comparing polyp detection (both neoplastic and non- neoplastic polyps) in patients submitted to conventional colonoscopy or colonoscopy with chromoscopy. Chromoscopy was associated with a significant improvement in all detection endpoints (number of polyps, number of neoplastic polyps, number of diminutive polyps, number of neoplastic diminutive polyps, proportion of patients with at least one polyp and proportion of patients with at least one neoplastic polyp). However, when highdefinition colonoscopes were used in the control group, chromoscopy benefit does not seem to be significant. Besides, routine use of chromoscopy may have implications in the accessibility of colonoscopy and in the effectiveness of screening programs. Moreover, the benefit of chromoscopy in the era of high-definition colonoscopy is questionable.


2020 ◽  
Vol 63 (2) ◽  
pp. 34-43 ◽  
Author(s):  
Hamid Reza Shoraka ◽  
Ali Akbar Haghdoost ◽  
Mohammad Reza Baneshi ◽  
Zohre Bagherinezhad ◽  
Farzaneh Zolala

Phenylketonuria is a disease caused by congenital defects in phenylalanine metabolism that leads to irreversible nerve cell damage. However, its detection in the early days of life can reduce its severity. Thus, many countries have started disease screening programs for neonates. The present study aimed to determine the worldwide prevalence of classic phenylketonuria using the data of neonatal screening studies. The PubMed, Web of Sciences, Sciences Direct, ProQuest, and Scopus databases were searched for related articles. Article quality was evaluated using the Joanna Briggs Institute Critical Appraisal Evaluation Checklist. A random effect was used to calculate the pooled prevalence, and a phenylketonuria prevalence per 100,000 neonates was reported. A total of 53 studies with 119,152,905 participants conducted in 1964–2017 were included in this systematic review. The highest prevalence (38.13) was reported in Turkey, while the lowest (0.3) in Thailand. A total of 46 studies were entered into the meta-analysis for pooled prevalence estimation. The overall worldwide prevalence of the disease is 6.002 per 100,000 neonates (95% confidence interval, 5.07–6.93). The metaregression test showed high heterogeneity in the worldwide disease prevalence (<i>I</i><sup>2</sup>=99%). Heterogeneity in the worldwide prevalence of phenylketonuria is high, possibly due to differences in factors affecting the disease, such as consanguineous marriages and genetic reserves in different countries, study performance, diagnostic tests, cutoff points, and sample size.


2021 ◽  
pp. 106927
Author(s):  
Valentina Baccolini ◽  
Claudia Isonne ◽  
Carla Salerno ◽  
Monica Giffi ◽  
Giuseppe Migliara ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document